Press releases

articles from August 2018

Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline

Proceeds to advance three late-stage programs towards registration, prepare for commercialization and progress the company’s gene therapy platform

Read more

Orchard Therapeutics Appoints Jon Ellis to Board of Directors

Orchard Therapeutics today announced the appointment of Jon Ellis, Ph.D. as GSK’s designated representative to its board of directors. Dr. Ellis is currently vice president and head of science & technology licensing at GlaxoSmithKline (GSK)

Read more